Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.46 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL72171 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL938198 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL29777001 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6532887 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6309997 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL72682 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL883098 | 1.00 | TP53 (0.68) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL19279013 | 0.98 | TP53 (0.66) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| Water SCHEMBL1322822 | 0.98 | TP53 (0.66) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 | |
| Water SCHEMBL743190 | 0.98 | TP53 (0.66) | TP53TSHRTDP1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7240 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714955-A1 | VERSATILE INTERMEDIATE FOR OPIOID DERIVATIVES, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shaoxing Zejun Pharmaceuticals Co., Ltd (CN) | 2026-03-25 | — | — | EP | claimed |
| US-12441745-B2 | Processes and compounds | RADIUS PHARMACEUTICALS, INC. (US) | 2025-10-14 | — | — | US | claimed |
| CN-119954778-A | Synthesis method of lenacipam sodium and series of intermediate compounds thereof | 杭州科巢生物科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119569588-A | Preparation method and intermediate of ilast hydrochloride | 杭州诺澳生物医药科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119409612-A | Resolution refining method of clemastine fumarate | 南京斯泰尔医药科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-113348163-B | Methods and compounds | 雷迪厄斯制药公司 | 2024-10-08 | — | — | CN | claimed |
| WO-2024130425-A1 | METHODS OF MAKING 2-AMINO-L-(3-HYDROXY-2,6-DIMETHYLPHENYL)-5,6- DIMETHYL-LH-PYRROLO-[2,3-B]PYRIDINE-3-CARBOXAMIDE, A MYTL INHIBITOR | REPARE THERAPEUTICS INC. (CA) | 2024-06-27 | — | — | WO | claimed |
| US-20240208903-A1 | ACID ADDITION SALTS OF (S)-3-(2,5-DIMETHOXY-4-(TRIFLUOROMETHYL)PHENYL)PIPERIDINE AND (S)-3-(2-METHOXY-5-(METHYLTHIO)-4-(TRIFLUOROMETHYL)PHENYL)PIPERIDINE, SPECIFIC POLYMORPHS THEREOF AND METHODS FOR THEIR MANUFACTURE | Lophora ApS (DK) | 2024-06-27 | — | — | US | claimed |
| CN-118165070-A | Salt and crystal form of 3CL protease small molecule inhibitor, and preparation methods and applications thereof | 北京华益健康药物研究中心 | 2024-06-11 | — | — | CN | claimed |
| US-11999741-B2 | Process for the synthesis of 6-((3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-3-(tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one | CARDURION PHARMACEUTICALS, INC. (US) | 2024-06-04 | — | — | US | claimed |
| EP-0575482-A1 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1993-12-29 | — | — | EP | claimed |
| EP-0539460-A1 | SALTS DERIVED FROM DIALKYLAMINOALKYLSULPHONYL-26 PRISTINAMYCIN II B. | RHONE POULENC RORER SA (FR) | 1993-05-05 | — | — | EP | claimed |
| WO-1992014743-A2 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1992-09-03 | — | — | WO | claimed |
| WO-1992001694-A1 | NEW SALTS DERIVED FROM DIALKYLAMINOALKYLSULPHONYL-26 PRISTINAMYCIN II¿B? | RHONE-POULENC RORER S.A. (FR) | 1992-02-06 | — | — | WO | claimed |
| US-4931557-A | Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof | ELI LILLY AND COMPANY (US) | 1990-06-05 | — | — | US | claimed |
| EP-0365213-A2 | Method of resolving cis 3-amino-4-[2-(2-furyl)vinyl]-1-methoxy-carbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof | ELI LILLY AND COMPANY (US) | 1990-04-25 | — | — | EP | claimed |
| EP-0251904-B1 | PROCESS FOR THE PREPARATION OF ACIDIC LEVOMEPROMAZINE MALEATE | RHONE-POULENC SANTE (FR) | 1990-01-10 | — | — | EP | claimed |
| US-4798895-A | Process for preparing levomepromazine hydrogen maleate | RHONE-POULENC SANTE (FR) | 1989-01-17 | — | — | US | claimed |
| US-4471121-A | Method of resolving trans-d alpha-1-n-propyl-6-oxodecahydroquinoline and di-p-toluoyltartaric acid salts thereof | ELI LILLY AND COMPANY (US) | 1984-09-11 | — | — | US | claimed |
| EP-0112604-A1 | Novel resolved keto compounds and process | ELI LILLY AND COMPANY (US) | 1984-07-04 | — | — | EP | claimed |